Peptide Product Composition: Glucagon Structure and Key Functional Domains
Title: Peptide Product Composition: Glucagon Structure and Key Functional Domains Abstract: Glucagon, a 29-amino-acid peptide, features a critical N-terminal His-Ser-Gln-Gly domain for receptor activation and a C-terminal helical region for binding stability. Current market trends show a 12.3% CAGR (2024–2030) driven by diabetes and hypoglycemia management. Leading brands (e.g., Novo Nordisk, Eli Lilly) dominate via recombinant technology, offering high purity (>98%) but higher costs versus synthetic analogs. Key quality parameters include aggregation levels (<2%) and endotoxin limits (<0.5 EU/mg). Selection criteria prioritize GMP-certified facilities, stability data, and cold-chain logistics (2–8°C). Industry challenges include batch consistency and regulatory compliance (FDA/EMA).